Human Cord Tissue Derived Mesenchymal Stromal Cell Therapy

N/A

Report date: 2025/03/28 14:47:21

Base Information

Drug NameHuman Cord Tissue Derived Mesenchymal Stromal Cell Therapy
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Marcus Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Marcus FoundationDuke University
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A